国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

更新于 5月23日

商業(yè)健康保險洞察與卓越執(zhí)行高級經(jīng)理

5-5.5萬
  • 上海靜安區(qū)
  • 5-10年
  • 本科
  • 全職
  • 招1人

雇員點評標(biāo)簽

  • 同事很nice
  • 團(tuán)隊執(zhí)行強
  • 工作環(huán)境好
  • 人際關(guān)系好
  • 氛圍活躍
  • 實力大公司

職位描述

藥企
Job Summary: The CHI Landing Insight & Excellence Manager is responsible for enhancing the operational excellence of CHI (Commercial Health Insurance) projects by establishing seamless governance for the full lifecycle management of CHI projects and post-launch landing excellence. This role focuses on high-quality execution and risk management of CHI projects, and support for strategic market access and innovative access initiatives. The successful candidate must demonstrate a strong understanding of project management principles, innovative access strategies, and the ability to collaborate effectively with internal and external stakeholders. Responsibilities: ● Support MAx and CHI strategic planning ● Support the development of strategic plans for MAx and CHI initiatives, ensuring alignment with organizational goals and market needs. ● Identify opportunities for improvement and implement strategies to enhance efficiency and effectiveness of responsible CHI projects ● Drive CHI Operation Excellence through Seamless Governance ● Drive and coordinate cross-functional teams to develop, update and optimize CHI SOP and other governance documents. Ensure the governance frameworks are aligned with industry’s best practices and organizational objectives. ● Analyze to identify inefficiencies, bottlenecks, and areas for improvement, and optimize project process to streamline operations and enhance overall project efficiency. ● Provide insights and recommendations based on project execution data and industry trends. ● Support key Market Access/Innovative Access strategy projects ● Ensure CHI Project Execution Excellence and maximize business impact on key projects ● Implement the CHI project risk grading management system to achieve full lifecycle management of CHI SOP ● Algn risk management Align risk management practices with CHI SOPs to ensure consistency and effectiveness, and collaborate with cross-functional teams on risk monitoring and response Mechanisms ● Liaise with Third-Party Administrators (TPAs) to manage the execution and follow-up of CHI projects at post-launch stage ● Monitor project milestones and deliverables and provide progress reports to internal stakeholders ● Closely work with insurers towards innovative CHI projects by understanding industry best practices. Education and Experience: ● 6+ years’ experience in insurance company, TPA or related department in MNC. ● Project Management Expertise: Strong understanding of project management principles and methodologies. ● Innovative Access Knowledge: Familiarity with innovative access strategies and market access initiatives. ● Analytical Abilities: Strong analytical skills to identify inefficiencies and drive process improvements. ● Demonstrated ability to work effectively across cultures and the agility to deliver results quickly in new and unfamiliar situations. ● Good understanding in social and commercial payer system and market dynamic. Technical Skills Requirements: ● Communication and Impact – Excellent presentation and some influencing skill ability to interact with key decision maker internally and externally. Ability to use influencing skills to make advantage in listing and scheme designing. ● Program management – Excellent ability to review and use data to develop insights and support decisions ● Business development – Explore HQ and local insurance company resources to develop potential programs Work Location Assignment: On Premise Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates. Market Access #LI-PFE

工作地點

上海靜安區(qū)中信泰富廣場

職位發(fā)布者

劉一飛/人事經(jīng)理

當(dāng)前在線
立即溝通
公司Logo輝瑞投資有限公司公司標(biāo)簽
輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國紐約,是一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來改變其生活的突破創(chuàng)新”。在輝瑞,我們通過科學(xué)和全球資源為人們提供治療方案,以延長其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產(chǎn)品的探索、研發(fā)和生產(chǎn)過程中,輝瑞始終致力于奉行嚴(yán)格的質(zhì)量、安全和價值標(biāo)準(zhǔn)。我們在全球的產(chǎn)品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達(dá)和新興市場的員工都在推進(jìn)人類健康,推動疾病的預(yù)防、治療和治愈,以應(yīng)對挑戰(zhàn)我們這個時代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務(wù)方、政府和社區(qū)合作,支持并促進(jìn)世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務(wù)。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責(zé)任是一致的。170余年來,輝瑞一直致力于為所有依賴我們的人帶來改變。輝瑞于1989年進(jìn)入中國市場。扎根中國30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開始。迄今已有170余年歷史的輝瑞正在邁入全新時代,成為一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國業(yè)務(wù)覆蓋全國300余個城市,累計投資超過15億美元,并設(shè)立了1家先進(jìn)的生產(chǎn)設(shè)施,2個研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務(wù)、研發(fā)和生產(chǎn)等領(lǐng)域。輝瑞在華上市了五大領(lǐng)域的高品質(zhì)創(chuàng)新產(chǎn)品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見病等多個領(lǐng)域的處方藥和疫苗,強大完善的產(chǎn)品線旨在滿足生命各階段的健康需求。
公司主頁